Gliflozin drugs are a class of medications that inhibit reabsorption of glucose in the kidneys and therefore lower blood sugar. They act by inhibiting sodium-glucose transport protein 2, and are therefore also called SGLT-2 inhibitors. These drugs include:

NOTE: Drugs in the class called SGLT-2 inhibitor increase your risk of developing diabetic ketoacidosis (DKA), a dangerous and potentially fatal condition. Mainstream medicine/healthcare providers seem largely unaware of this and that makes it even scarier. Several diabetics have already been hospitalized for DKA following the addition of SGLT2 meds; all survived, but we don’t want any more people put at risk. YOU may have to educate your healthcare provider on this – and by doing so, you will help others as well as yourself.


SGLT-2 Inhibitors

Invokana: Diabetes Drug Gets Black Box Warning for Amputation Risks
SGLT-2 drug

Classes of Medications